ESR1 and breast cancer: Furthermore, in the estrogen receptor-negative (ER-) breast cancer cell line MDA-MB-231, 150 μM calycosin reduces the expression of Rab27B and its downstream β-catenin-induced VEGF expression to inhibit cancer cell migration and invasion [182].